Accéder au contenu
Merck

[Interest of an intensive chemotherapy for intravascular large B cell lymphoma].

Bulletin du cancer (2013-04-17)
Aurélie Baldolli, Marie Chuffart, Loik Geffray, Laurence Verneuil, Oumédaly Reman
RÉSUMÉ

We describe three cases of intravascular lymphoma B with different clinical presentation: one case of a cutaneous variant and two cases with surrenal and cutaneous localisation. All patients are in complete remission after chemotherapy alone or after chemotherapy and autologous stem cells transplantation. The review of the literature as well as our cases specify the interest of an aggressive chemotherapy with autologous of peripheral stem cells if it was possible.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Sulfate de bléomycine from Streptomyces verticillus, crystalline, 1.5-2.0 U/mg
Sigma-Aldrich
Sulfate de bléomycine from Streptomyces verticillus, BioXtra, crystalline
Sigma-Aldrich
Sulfate de bléomycine from Streptomyces verticillus, 1.5-2.0 units/mg solid, BioReagent, suitable for cell culture
Sigma-Aldrich
Sulfate de bléomycine from Streptomyces verticillus, for fluorescence, mixture of bleomycin sulfate salts, lyophilized, powder or crystals, white to off-white
Sigma-Aldrich
Vindesine sulfate salt hydrate, ≥95% (HPLC)